# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-13-028606
Filing Date
2013-05-14
Accepted
2013-05-14 14:35:29
Documents
23
Period of Report
2013-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v345017_8k.htm | 8-K | 19530
2 | EX-99.1 | v345017_ex99-1.htm | EX-99.1 | 32509
3 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 40739
4 | GRAPHIC | ex99x1_002.jpg | GRAPHIC | 105503
5 | GRAPHIC | ex99x1_003.jpg | GRAPHIC | 49530
6 | GRAPHIC | ex99x1_004.jpg | GRAPHIC | 54292
7 | GRAPHIC | ex99x1_005.jpg | GRAPHIC | 61770
8 | GRAPHIC | ex99x1_006.jpg | GRAPHIC | 48135
9 | GRAPHIC | ex99x1_007.jpg | GRAPHIC | 59540
10 | GRAPHIC | ex99x1_008.jpg | GRAPHIC | 72958
11 | GRAPHIC | ex99x1_009.jpg | GRAPHIC | 44553
12 | GRAPHIC | ex99x1_010.jpg | GRAPHIC | 48838
13 | GRAPHIC | ex99x1_011.jpg | GRAPHIC | 68677
14 | GRAPHIC | ex99x1_012.jpg | GRAPHIC | 84957
15 | GRAPHIC | ex99x1_013.jpg | GRAPHIC | 58396
16 | GRAPHIC | ex99x1_014.jpg | GRAPHIC | 64993
17 | GRAPHIC | ex99x1_015.jpg | GRAPHIC | 62514
18 | GRAPHIC | ex99x1_016.jpg | GRAPHIC | 46398
19 | GRAPHIC | ex99x1_017.jpg | GRAPHIC | 50183
20 | GRAPHIC | ex99x1_018.jpg | GRAPHIC | 46642
21 | GRAPHIC | ex99x1_019.jpg | GRAPHIC | 40068
22 | GRAPHIC | ex99x1_020.jpg | GRAPHIC | 70029
23 | GRAPHIC | ex99x1_021.jpg | GRAPHIC | 64884
| Complete submission text file | 0001144204-13-028606.txt |  | 1769896

Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 13840893
SIC: 2834 Pharmaceutical Preparations